Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
通过创新纳米材料介导的药物输送使衰老的骨再生恢复活力
基本信息
- 批准号:10045736
- 负责人:
- 金额:$ 36.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAdultAgingAnti-Inflammatory AgentsAutologousAutologous TransplantationBiomimeticsBone DiseasesBone MatrixBone Morphogenetic ProteinsBone RegenerationBone TissueBone TransplantationCell TransplantationCellsCephalicChitosanChronicCost of IllnessDefectDeferoxamineDrug Delivery SystemsEffectivenessElasticityElderlyElectrospinningEndothelial CellsEngineeringFemaleFibrinogenGoalsGoldGrowth FactorHA coatingHIF1A geneHealthcareHormonesHumanHypoxiaImmobilizationIn SituIn VitroInflammationInflammatoryIronIron Chelating AgentsIrregular BoneKnowledgeMediatingMedicalMesenchymal Stem CellsModelingModernizationMolecularMusNatural regenerationOlder PopulationOsteogenesisPatientsPharmaceutical PreparationsPlayPolymersPopulationPrevalenceProductionProteinsRegenerative MedicineResearchRoleSafetySignal PathwaySignal TransductionSignaling ProteinSomatotropinStem cell transplantStructureSystemTechniquesThe SunTherapeuticTissue EngineeringTissuesTranslationsTransplantationWorkage relatedagedaging populationangiogenesisbonebone agingcell agecell growthchemical conjugatechemical propertyclinically relevantcombinatorialcontrolled releasecostcytokinehuman stem cellsimprovedinnovationlocal drug deliverymalemechanical propertiesnanofibernanomaterialsnew therapeutic targetnext generationnovelnovel strategiesosteoblast differentiationosteogenicphenylamilrecruitrepairedrestorationscaffoldsmall moleculestemsuccesstissue regeneration
项目摘要
PROJECT SUMMARY
Scaffold-mediated exogenous cells transplantation and growth factors/hormones delivery are
two widely-studied alternatives to conventional autologous grafts, the "gold standard." For
therapeutic translation, however, both approaches encounter various barriers, including safety
concerns. Compared to use of exogenous cells/proteins, strategies that promote tissue
regeneration by leveraging endogenous cells/signals in situ are more intriguing. Nonetheless,
changes in tissue associated with aging (iron accumulation and chronic inflammation) challenge
bone regeneration and repair, particularly in older populations. Emerging evidence suggests
that the hypoxia-induced factor-1α (HIF-1α) signaling pathway is a central driver of regeneration
and angiogenesis. Findings also show sustained activation of HIF-1α by an iron chelator (e.g.,
Deferoxamine, DFO) is a promising strategy to improve the capacity of regeneration in aged
bones where HIF-1α is markedly inhibited by elevated iron levels. Preliminary work by the Sun
lab has found that another small molecule, phenamil, shows strong anti-inflammatory ability in
addition to playing a powerful role in promoting bone formation by targeting BMP signaling. A
locally and sustained drug delivery system and a bio-mimicking scaffold are critical for
successful translational application of these promising small molecular drugs. The primary goal
of this study is to develop an innovative translational tissue engineering strategy to improve
aged large bone regeneration by rejuvenating endogenous signals and reparative cells. Our
central hypothesis is that novel bio-mimicking 3D nanofibrous (NF) scaffold-mediated dual-
release of small molecules, DFO and phenamil, can improve critical-sized bone defect repair in
aged mice through locally: (1) scavenging for detrimental aged-related factors, i.e., excessive
iron and inflammatory cytokines; and (2) activating HIF1α and BMP signaling pathways, thereby
promoting production of endogenous angiogenic and osteogenic factors, and recruitment of
reparative cells (e.g., MSCs, endothelial cells) in situ, for bone regeneration with a primary focus
on non-load-bearing bone defects. In Aim 1, we will develop novel, biomimetic 3D NF scaffolds,
using our innovative technique of thermally induced nanofiber self-agglomeration (TISA). In Aim
2, we will develop the dual-release system of DFO and phenamil from a 3D NF scaffold to
modulate both angiogenesis and osteogenesis in aged cells in vitro. In Aim 3, we will investigate
the contribution of local and controlled release of DFO and phenamil from scaffolds for critical-
sized cranial bone defect repair in aged mice. The success of this project will establish a novel
strategy for challenged bone repair by improving endogenous tissue regeneration.
项目摘要
支架介导的外源性细胞移植和生长因子/激素的递送是
两种被广泛研究的传统自体移植物的替代品,即“金标准”。“对于
然而,治疗转化,这两种方法都遇到了各种障碍,包括安全性
性问题与使用外源性细胞/蛋白质相比,促进组织生长的策略
通过原位利用内源性细胞/信号的再生更有趣。尽管如此,
与衰老(铁积累和慢性炎症)挑战相关的组织变化
骨再生和修复,特别是在老年人群中。新出现的证据表明
缺氧诱导因子-1 α(HIF-1α)信号通路是再生的中心驱动力,
和血管生成。研究结果还显示,铁螯合剂(例如,
去铁胺(Deferoxamine,DFO)是一种很有前途的提高老年人再生能力的策略
骨中HIF-1α明显受到铁水平升高的抑制。太阳的初步工作
实验室发现,另一种小分子,非那灭,显示出强烈的抗炎能力,
除了通过靶向BMP信号传导在促进骨形成中发挥强有力的作用之外。一
局部和持续的药物递送系统和生物模拟支架对于
这些有前途的小分子药物的成功转化应用。首要目标
这项研究的目的是开发一种创新的转化组织工程策略,
通过再生内源性信号和修复细胞来再生老化的大骨。我们
中心假设是,新的生物模拟3D纳米纤维(NF)支架介导的双-
释放小分子DFO和非那米,可以改善临界大小的骨缺损修复,
老年小鼠通过局部:(1)清除有害的年龄相关因子,即,过度
铁和炎性细胞因子;和(2)激活HIF 1 α和BMP信号通路,从而
促进内源性血管生成因子和成骨因子的产生,
修复细胞(例如,MSC,内皮细胞)原位,用于主要关注的骨再生
非承重性骨缺损在目标1中,我们将开发新型的仿生3D NF支架,
使用我们的创新技术热诱导自附聚(TISA)。在Aim中
2、将DFO和非那敏的双释放系统从三维纳米支架发展到
调节体外老化细胞中的血管生成和骨生成。在目标3中,我们将研究
DFO和非那米从支架中的局部和控制释放对关键-
大小的颅骨缺损修复。这个项目的成功将建立一个新的
通过改善内源性组织再生进行挑战性骨修复的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hongli Sun其他文献
Hongli Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hongli Sun', 18)}}的其他基金
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
通过创新纳米材料介导的药物输送使衰老的骨再生恢复活力
- 批准号:
10194462 - 财政年份:2020
- 资助金额:
$ 36.48万 - 项目类别:
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
通过创新纳米材料介导的药物输送使衰老的骨再生恢复活力
- 批准号:
10615065 - 财政年份:2020
- 资助金额:
$ 36.48万 - 项目类别:
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery
通过创新纳米材料介导的药物输送使衰老的骨再生恢复活力
- 批准号:
10391345 - 财政年份:2020
- 资助金额:
$ 36.48万 - 项目类别:
Functionalized Nanofibrous Scaffold for Endogenous Bone Regeneration
用于内源性骨再生的功能化纳米纤维支架
- 批准号:
9770013 - 财政年份:2018
- 资助金额:
$ 36.48万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.48万 - 项目类别:
Research Grant